Gastrointestinal

Main information

  • Trade name:
  • Gastrointestinal guidewire
  • Class:
  • Class 1
  • Medicine domain:
  • Humans
  • Medicine type:
  • Medical device

Documents

Localization

  • Available in:
  • Gastrointestinal guidewire
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 217185
  • Last update:
  • 09-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

217185

Getinge Australia Pty Ltd - Gastrointestinal guidewire

ARTG entry for

Medical Device Included Class 1

Sponsor

Getinge Australia Pty Ltd

Postal Address

PO Box 50,BULIMBA, QLD, 4171

Australia

ARTG Start Date

12/11/2013

Product category

Medical Device Class 1

Status

Active

Approval area

Medical Devices

Conditions

- The inclusion of the kind of device in the ARTG is subject to compliance with all conditions placed or imposed on the ARTG entry. Refer Part 4-5,

Division 2 (Conditions) of the Therapeutic Goods Act 1989 and Part 5, Division 5.2 (Conditions) of the Therapeutic Goods (Medical Devices) Regulations

2002 for relevant information.

- Breaching conditions of the inclusion related to the device of the kind may lead to suspension or cancellation of the ARTG entry; may be a criminal

offence; and civil penalties may apply.

Manufacturers

Name

Address

Maquet Critical Care AB

Rontgenvagen 2

Solna, , SE-171 54

Sweden

Products

1. Gastrointestinal guidewire

Product Type

Single Device Product

Effective date

12/11/2013

GMDN

46667 Gastrointestinal guidewire

Intended purpose

The guide wire is intended to be used to aid with the positioning of a catheter.

Specific Conditions

No Specific Conditions included on Record

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 1 of

Produced at 10.11.2017 at 03:06:56 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

29-6-2018

Medicines Safety Update, Volume 9, Number 2, June 2018

Medicines Safety Update, Volume 9, Number 2, June 2018

Oral methotrexate dosing, medicines associated with a risk of neuropsychiatric adverse events, and clozapine and gastrointestinal effects

Therapeutic Goods Administration - Australia

7-5-2018

FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding

FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding

FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding

FDA - U.S. Food and Drug Administration

There are no news related to this product.